INZY
Inozyme Pharma
INZY
INZY
Delisted
INZY was delisted on the 30th of June, 2025.
55 hedge funds and large institutions have $379M invested in Inozyme Pharma in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 5 closing their positions.
Holders
55
Holders Change
+1
Holders Change %
+1.85%
% of All Funds
0.97%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
6
Increased
21
Reduced
11
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
DM
1
Deerfield Management
New York
|
$38.9M |
| 2 |
2
BlackRock
New York
|
$17.1M |
| 3 |
3
Adage Capital Partners
Boston,
Massachusetts
|
$21.6M |
| 4 |
CCM
4
CAAS Capital Management
New York
|
$3.52M |
| 5 |
5
Millennium Management
New York
|
$2.95M |
Top Sellers
| 1 |
NHAS
1
Novo Holdings A/S
Hellerup,
Denmark
|
$39M |
| 2 |
O
2
OrbiMed
New York
|
$0 |
| 3 |
YU
3
Yale University
New Haven,
Connecticut
|
$0 |
| 4 |
CA
4
CHI Advisors
New York
|
$18.4M |
| 5 |
5
D.E. Shaw & Co
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AIP
51
Ameritas Investment Partners
Lincoln,
Nebraska
| $14K | – | – | – |
|
|
PCM
52
Penserra Capital Management
Orinda,
California
| $10K | -$94 | -5 | -0.9% |
|
53
Bank of Montreal
Toronto,
Ontario, Canada
| $7K | -$15.8K | -877 | -69% |
|
54
Daiwa Securities Group
Tokyo,
Japan
| $1K | – | – | – |
|
|
AIG
55
American International Group
New York
| $139 | +$45 | +2,287 | +48% |
|
|
O
56
OrbiMed
New York
| – | -$8.26M | -400,400 | Closed |
|
|
YU
57
Yale University
New Haven,
Connecticut
| – | -$2.34M | -113,502 | Closed |
|
|
58
D.E. Shaw & Co
New York
| – | -$248K | -12,016 | Closed |
|
|
APM
59
Avidity Partners Management
Dallas,
Texas
| – | -$200K | -9,683 | Closed |
|
|
RFA
60
Reilly Financial Advisors
La Mesa,
California
| – | -$2K | -100 | Closed |
|